Anticonvulsant drugs for migraine prophylaxis

Cochrane Database of Systematic Reviews

Volumn 2004, Issue 3, 2004, Pages

  Chronicle, Edward P ^a   Mulleners, Wim M ^b  

^a UNIVERSITY OF HAWAII   (United States)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

ADULT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; META ANALYSIS; MIGRAINE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ADULT; ANTICONVULSANTS; HUMANS; MIGRAINE DISORDERS; RANDOMIZED CONTROLLED TRIALS;

EID: 16544374680     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD003226.pub2     Document Type: Review

References (88)

1. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291(8):965-73.
2. Diener HC, Tfelt-Hansen P, Dahlöf C, Lainez MJA, Sandrini G, Wang SJ, et al. Topiramate in migraine prophylaxis: results from a placebo-controlled trial with propanolol as an active control. Journal of Neurology 2004;251(8):943-50.
3. Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. Clinica Terapeutica 2000;151(3):145-8.
4. Edwards KR, Glantz MJ, Norton JA, Cross N. Prophylactic treatment of episodic migraine with topiramate: a double-blind, placebo-controlled trial in 30 patients. Cephalalgia 2000;20(4):316.
5. Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 2002;58(11):1652-9.
6. Ghose K, Niven BE, Berry D. A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache. Journal of Headache & Pain 2002;3(2):79-85.
7. Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 1992;12(2):81-4.
8. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 1994;44(4):647-51.
9. Jimenez-Hernandez MD, Torrecillas-Narvaez MD, Friera-Acebal G. Effectiveness and safety of gabapentin in the preventive treatment of migraine [Eficacia y seguridad de la gabapentina en el tratamiento preventivo de la migrana]. Revista de Neurologia 2002;35:603-6.
10. Kaniecki RG. A comparison of divalproex with propanolol and placebo for the prophylaxis of migraine without aura. Archives of Neurology 1997;54(9):1141-5.
11. Kinze S, Clauss M, Reuter U, Wolf T, Dreier JP, Einhaupl KM, et al. Valproic acid is effective in migraine prophylaxis at low serum levels: a prospective open-label study. Headache 2001;41(8):774-8.
12. Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997;17(7):103-8.
13. Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, et al. Migraine prophylaxis with divalproex. Archives of Neurology 1995;52(3):281-6.
14. Mathew NT, Rapoport A, Saper J, Magnus L, Klapper J, Ramadan N, et al. Efficacy of gabapentin in migraine prophylaxis. Headache 2001;41(2):119-28.
15. Mei D, Capuano A, Vollono C, Evangelista M, Ferraro D, Tonali P, et al. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. Neurological Sciences 2004;25(5):245-50.
16. Mitsikostas DD, Polychronidis I. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial. Functional Neurology 1997;12(5):267-76.
17. Rompel H, Bauermeister PW. Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study. South African Medical Journal 1970;44(4):75-80.
18. Shaygannejad V, Janghorbani M, Ghorbani A, Ashtary F, Zakizade N, Nasr V. Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded crossover study. Headache 2006;46(4):642-8.
19. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Archives of Neurology 2004;61(4):490-5.
20. Steiner TJ, Findley LJ, Yuen AWC. Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 1997;17(2):109-12.
21. Stensrud P, Sjaastad O. Clonazepam (Rivotril) in migraine prophylaxis. Headache 1979;19(6):333-4.
22. Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001;41(10):968-75.
23. Vahedi K, Taupin P, Djomby R, El-Amrani M, Lutz G, Filipetti V, et al. Efficacy and tolerability of acetazolamide in migraine prophylaxis: a randomized placebo-controlled trial. Journal of Neurology 2002;249(2):206-11.
24. Anthony M, Lance JW, Somerville B. A comparative trial of prindolol, clonidine and carbamazepine in the interval therapy of migraine. The Medical Journal of Australia 1972;1(26):1343-6.
25. Arnold G, Einhaupl KM. Valproic acid in the prophylactic treatment of migraine [Valproinsaure in der prophylaktischen Behandlung der Migräne]. Nervenarzt 1998;69(10):913-8.
26. Bartolini M, Silvestrini M, TaffiR, Lanciotti C, Luconi R, Capecci M, et al. Efficacy of topiramate and valproate in chronic migraine. Clinical Neuropharmacology 2005;28(6):277-9.
27. Chen WT, Fuh JL, Lu SR, Wang SJ. Persistent migrainous visual phenomena might be reponsive to lamotrigine. Headache 2001;41(8):823-5.
28. Cochran JW. Levetiracetam as migraine prophylaxis. Clinical Journal of Pain 2004;20(3):198-9. [PMID 15100599]
29. Cutrer FM. Antiepileptic drugs: how they work in headache. Headache 2001;41 Suppl 1:S3-S10.
30. D'Andrea G, Granella F, Cadaldini M, Manzoni GC. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 1999;19(1):64-6.
31. Delvaux V, Schoenen J. New generation anti-epileptics for facial pain and headache. Acta Neurologica Belgica 2001;101(1):42-6.
32. Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Topiramate as prophylactic treatment in migraine [Topiramate nella terapia di profilassi dell'emicrania]. Acta Medica Romana 2000;38(1-2):164-8.
33. Edwards KR, Potter DL, Wu SC, Kamin M, Hulihan J. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. CNS Spectrums 2003;8(6):428-32. [PMID 12858132]
34. Erdemoglu AK, Ozbakir S. Valproic acid in prophylaxis of refractory migraine. Acta Neurologica Scandinavica 2000;102(6):354-8.
35. Fragoso YD. Low dose of sodium divalproate for the treatment of migraine. MedGenMed [electronic resource]: Medscape General Medicine 2003;5(1):32. [PMID12827093]
36. Freitag FG. Topiramate prophylaxis in patients suffering from migraine with aura: results from a randomized, double-blind, placebo-controlled trial. Advanced Studies in Medicine 2003;3(6C):S562-4.
37. Ghose K, Niven B. Prophylactic sodium valproate therapy in patients with drug-resistant migraine. Methods & Findings in Experimental & Clinical Pharmacology 1998;20(4):353-9.
38. Hart CE, Dodick DW, Brandes JL, Rothrock JF, Jacobs D, Neto W, et al. Migraine prpophylaxis with topiramate: results of double-blind, placebo-controlled, dose-response trials. Epilepsia 2003;44 Suppl 9:106-7.
39. Hedri A. Rivotril in migraine [Rivotril bei Migräne]. Schweizerische Rundschau für Medizin Praxis 1975;64(33):1062-3.
40. Jimenez MD, Freira G, Morales A, Cuartero F, Morralla C, Sol JM, et al. Gabapentine in the prophylaxis of migraine. A pilot study [Gabapentina en la profilaxis de la migrana. Estudio piloto]. Neurologia 1999;14(10):478.
41. Klapper JA. An open label cross-over comparison of divalproex sodium and propanolol HCl in the prevention of migraine headaches. Headache Quarterly 1994;5(4):50-3.
42. Lampl C, Buzath A, Klinger D, Neumann K. Lamotrigine in the prophylactic treatment of migraine aura - a pilot study. Cephalalgia 1999;19(1):58-63.
43. Lenaerts M, Bastings E, Sianard J, Schoenen J. Sodium valproate in severe migraine and tension-type headache: an open study of long-term efficacy and correlation with blood levels. Acta Neurologica Belgica 1996;96(2):126-9.
44. Li ZX, Li XG, Xiong XJ, Zhang ZL. A clinical study of sibelium combining topiramate in prophylactic treatment of migraine [original in Chinese]. Chinese Journal of Modern Applied Pharmacy 2002;19(5):419-21.
45. Merren MD. Gabapentin for treatment of pain and tremor: a large case series. Southern Medical Journal 1998;91(8):739-44.
46. Rothrock JF, Kelly NM, Brody ML, Golbeck A. A differential response to treatment with divalproex sodium in patients with intractable headache. Cephalalgia 1994;14(3):241-4.
47. Rothrock JF. Clinical studies of valproate for migraine prophylaxis. Cephalalgia 1997;17(2):81-3.
48. Silberstein SD, Saper JR, Mathew NT. The safety and efficacy of divalproex sodium in the prophylaxis of migraine headache: a multicenter, double-blind, placebo-controlled trial. Headache 1993;33(5):264-5.
49. Silberstein S, Karim R, Kamin M, Jordan D, Hulihan J. Topiramate prophylaxis in patients suffering from migraine with aura: results from a randomized, double-blind placebo-controlled trial. European Journal of Neurology 2002;9 Suppl 2:44.
50. Silberstein SD. Efficacy and safety of topiramate in migraine prevention: a dose-ranging, placebo-controlled, double-blind, multicenter study. Advanced Studies in Medicine 2003;3(6C):S565-8.
51. Silvestrini M, Bartolini M, Coccia M, Baruffaldi R, TaffiR, Provinciali L. Topiramate in the treatment of chronic migraine. Cephalalgia 2003;23(8):820-4.
52. Skupin G, Franzke HG. The role of chlorazepate dipotassium (Tranxilium) in the therapy of psychovegetative syndromes [Die Stellung von Dikalium-chlorazepat (Tranxilium) in der Therapie psychovegetativer Syndrome]. Medizinische Klinik 1975;70(31):1279-83.
53. Smirne S, Sinatra MG. Clonazepam in painful syndromes of the head [Il clonazepam nelle sindromi dolorose del distretto cefalico]. Rivista di Neurologia 1979;49(2):140-50.
54. Sorensen KV. Valproate: a new drug in migraine prophylaxis. Acta Neurologica Scandinavica 1988;78(4):346-8.
55. Spira PJ, Beran RG. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology 2003;61(12):1753-9.
56. Stieg RL. Double-blind study of belladonna-ergotamine-phenobarbital for interval treatment of recurrent throbbing headache. Headache 1977;17(3):120-4.
57. Voto Bernales J, Cruz G. Treatment of dysrhythmic migraines and other headaches with RO- 5-4023 [Tratamiento de la jaqueca distitmica y otras cefaleas con RO 5-4023]. Revista de Neuro-Psiquiatria 1974;37(1):1-8.
58. Wessely P, Baumgartner C, Klingler D, Kreczi J, Meyerson N, Sailer L, et al. Preliminary results of a double blind study with the new migraine prophylactic drug gabapentin. Cephalalgia 1987;7 Suppl 6:476-7.
59. Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 1962;179(9):717-8.
60. Alderson P, Green S, Higgins JPT, editors. Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE. Cochrane Reviewers' Handbook 4.2.2 [updated December 2003]; Appendix 5b. In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley & Sons, Ltd.
61. British Association for the Study of Headache. Guidelines for all doctors in the diagnosis and management of migraine and tension-type headache. 2nd edition (revised August 2004). Available at: http://www.bash.org.uk (accessed 12 November 2006).
62. Clarke CE, MacMillan L, Sondhi S, Wells NE. Economic and social impact of migraine. QJM 1996;89(1):77-84.
63. Cutrer FM, Limmroth V, Moskowitz MA. Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia 1997;17(2):93-100.
64. Dartigues JF, Michel P, Henri P. The economic burden of headache. In: Olesen J, Steiner TJ, Lipton RB editor(s). Reducing the burden of headache. Frontiers in headache research, vol. 11. Oxford: Oxford University Press, 2003:218-22.
65. Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ. Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey. Canadian Journal of Neurological Sciences 1993;20(2):131-7.
66. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999;319(7211):670-4.
67. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24 Suppl 1:1-160.
68. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8 Suppl 7:1-96.
69. Tfelt-Hansen P, Block G, Dahlöf C, Diener HC, Ferrari MD, Goadsby PJ, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000;20(9):765-86.
70. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
71. Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003225.pub2]
72. Marson AG, Kadir ZA, Chadwick DW. New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ 1996;313(7066):1169-74.
73. McQuay H, Moore R. An evidence-based resource for pain relief. Oxford: Oxford University Press, 1998.
74. Morrell MJ. Reproductive and metabolic disorders in women with epilepsy. Epilepsia 2003;44 Suppl 4:11-20.
75. Olesen J, Bousser M-G, Diener H-C, Dodick D, First M, Goadsby PJ, et al. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006;26(6):742-6.
76. Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG editor(s). Basic and clinical pharmacology. 5th Edition. Norwalk, CT: Appleton & Lange, 1992:331-49.
77. Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 1997;17(2):73-80.
78. Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. Journal of Epidemiology & Community Health 1992;46(4):443-6.
79. Reveiz-Herault L, Cardona AF, Ospina EG, Carrillo P. Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature [Eficacia de flunaricina en la profilaxis de migrana: revision metaanalitica de la bibliografia]. Revista de Neurologia 2003;36(10):907-12.
80. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;55(6):754-62.
81. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence. A review of population-based studies. Neurology 1994;44(6 Suppl 4):S17-23.
82. Victor S, Ryan S. Drugs for preventing migraine headaches in children. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD002761]
83. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database of Systematic Reviews 2000, Issue 3. [DOI: 10.1002/14651858.CD001133]
84. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010610]
85. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010611]
86. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010609]
87. Linde M, Mulleners WM, Chronicle EP, McCrory DC. Antiepileptics other than gabapentin, pregabalin, topiramate, and valproate for the prophylaxis of episodic migraine in adults. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD010608]
88. Mulleners WM, Chronicle EP. Anticonvulsants in migraine prophylaxis: a Cochrane review. Cephalalgia 2008;28(6):585-97. [MEDLINE: 18454787]